Literature DB >> 7874173

Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.

H Xu1, X R Wu, U M Wewer, E Engvall.   

Abstract

The classic murine muscular dystrophy strain, dy, was first described almost 40 years ago. We have identified the molecular basis of an allele of dy, called dy2J, by detecting a mutation in the laminin alpha 2 chain gene--the first identified mutation in laminin-2. The G to A mutation in a splice site consensus sequence causes abnormal splicing and expression of multiple mRNAs. One mRNA is translated into an alpha 2 polypeptide with a deletion in domain VI. The truncated protein apparently lacks important qualities of the wild type protein and is unable to provide sufficient muscle stability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874173     DOI: 10.1038/ng1194-297

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  100 in total

1.  Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.

Authors:  J F Talts; Z Andac; W Göhring; A Brancaccio; R Timpl
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.

Authors:  Jörg H O Garbe; Walter Göhring; Karlheinz Mann; Rupert Timpl; Takako Sasaki
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  Laminin expression in adult and developing retinae: evidence of two novel CNS laminins.

Authors:  R T Libby; M F Champliaud; T Claudepierre; Y Xu; E P Gibbons; M Koch; R E Burgeson; D D Hunter; W J Brunken
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

4.  Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle.

Authors:  U M Wewer; L E Thornell; F Loechel; X Zhang; M E Durkin; S Amano; R E Burgeson; E Engvall; R Albrechtsen; I Virtanen
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 5.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

Review 6.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Authors:  Jung Hae Yoon; Eric Johnson; Rui Xu; Laura T Martin; Paul T Martin; Federica Montanaro
Journal:  J Proteome Res       Date:  2012-07-30       Impact factor: 4.466

8.  Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation.

Authors:  Wei-Ming Yu; M Laura Feltri; Lawrence Wrabetz; Sidney Strickland; Zu-Lin Chen
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

Review 9.  p38 Mitogen-activated protein kinase regulates myelination.

Authors:  Jeffery D Haines; Gabriela Fragoso; Shireen Hossain; Walter E Mushynski; Guillermina Almazan
Journal:  J Mol Neurosci       Date:  2007-11-10       Impact factor: 3.444

10.  Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.

Authors:  W Kuang; H Xu; P H Vachon; L Liu; F Loechel; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.